Financials
- Market Capitalization 58.21 M
- Employee 33
- Founded 2011
- CEO N/A
- Website www.elicio.com
- Headquarter Delaware, United States
- FIGI BBG00444GM02
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4215 | EDSA Edesa Biotech, Inc. - Common Shares | 6.82 USD | +1.19% | -6.70% | +14.81% | +212.84% | 60.64 M USD | ||
| 4235 | CNTX Context Therapeutics Inc. - Common Stock | 0.63 USD | +1.61% | +5.00% | -10.00% | -18.18% | 57.88 M USD | ||
| 4243 | INKT MiNK Therapeutics, Inc. - Common Stock | 11.28 USD | -1.14% | +5.03% | -10.19% | +2.55% | 56.20 M USD | ||
| 4244 | TCRX TScan Therapeutics, Inc. - Common Stock | 0.91 USD | -2.15% | -27.78% | -3.19% | -49.16% | 55.58 M USD |
Frequently asked questions about Elicio Therapeutics, Inc. - Common Stock
What is the Elicio Therapeutics, Inc. - Common Stock stock price today?
The current price of Elicio Therapeutics, Inc. - Common Stock (ELTX) is 3.05. Over the past 24 hours, the stock has changed by -1.93%. Follow the ELTX chart for real-time price dynamics.
What is the stock ticker of Elicio Therapeutics, Inc. - Common Stock?
Elicio Therapeutics, Inc. - Common Stock trades under the ticker ELTX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Elicio Therapeutics, Inc. - Common Stock stock going up?
ELTX has changed by -12.61% over the last week, -24.88% over the last month, and -69.50% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Elicio Therapeutics, Inc. - Common Stock net income for the last quarter?
Elicio Therapeutics, Inc. - Common Stock reported net income of -11.82 M for the last quarter. The previous quarter showed -7.72 M, which means net income changed by -53.19%.
How many employees does Elicio Therapeutics, Inc. - Common Stock have?
As of the latest available data, Elicio Therapeutics, Inc. - Common Stock has 33 employees. Workforce size can provide additional context about the company's scale and operations.
What is Elicio Therapeutics, Inc. - Common Stock EBITDA?
Elicio Therapeutics, Inc. - Common Stock EBITDA is -10.47 M, and its EBITDA margin is -80.58 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Elicio Therapeutics, Inc. - Common Stock stock?
You can buy Elicio Therapeutics, Inc. - Common Stock (ELTX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Elicio Therapeutics, Inc. - Common Stock stock?
Investing in Elicio Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ELTX chart and related analysis on metatrader.com as part of your research.